Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplant
Title:
Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplant
Author:
Redfield, Robert R. Jordan, Stanley C. Busque, Stephan Vincenti, Flavio Woodle, E. Steve Desai, Niraj Reed, Elaine F. Tremblay, Simon Zachary, Andrea A. Vo, Ashley A. Formica, Richard Schindler, Thomas Tran, Ha Looney, Caroline Jamois, Candice Green, Cherie Morimoto, Alyssa Rajwanshi, Richa Schroeder, Aaron Cascino, Matthew D. Brunetta, Paul Borie, Dominic
Appeared in:
American journal of transplantation
Paging:
Volume 19 () nr. 11 pages 3035-3045
Year:
2019
Contents:
Publisher:
American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved.